Extensive research has identified various mechanisms driving prostate cancer progression, including androgen signaling, DNA repair systems, oncogenes and tumor suppressors, prostate-specific antigen, and transcription factors (Fontana et al., 2022). Here, KLK3 is linked to prostate carcinoma.